STAT3 and renal cell carcinoma: Entinostat (HDACi) blocked regulatory T cells (which negatively regulate the immune system and limit the efficacy of immunotherapy) in renal cell carcinoma via increased STAT3 acetylation, possibly due to increased CBP/p300 expression that acetylates STAT3 (131).